In the present work, we identified a MM subpopulation characterized by activated endoplasmic reticulum stress and upregulation of HSP90B1 and HSPA5, which confers resistance to anti-BCMA CAR-T therapy. This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.